ICAM1 and type 2 diabetes mellitus: MAPK-dependent modification of blood vessel development programs, including regulation of the expression of intercellular adhesion molecule-1 (ICAM-1), which is responsible for the recruitment of leukocytes to sites of inflammation [278], increases the risk of patients with type 2 diabetes, among others with vascular disease, experiencing more severe COVID-19 [279].